ES2550059T3 - Método para usar una cepa de Bacillus subtilis para la profilaxis y el tratamiento de afecciones gastrointestinales - Google Patents

Método para usar una cepa de Bacillus subtilis para la profilaxis y el tratamiento de afecciones gastrointestinales Download PDF

Info

Publication number
ES2550059T3
ES2550059T3 ES11710383.8T ES11710383T ES2550059T3 ES 2550059 T3 ES2550059 T3 ES 2550059T3 ES 11710383 T ES11710383 T ES 11710383T ES 2550059 T3 ES2550059 T3 ES 2550059T3
Authority
ES
Spain
Prior art keywords
bacillus subtilis
human
composition
prophylaxis
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11710383.8T
Other languages
English (en)
Spanish (es)
Inventor
Joseph Earl Schmidt
Desmond Rito Jimenez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer CropScience LP
Original Assignee
Bayer CropScience LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer CropScience LP filed Critical Bayer CropScience LP
Application granted granted Critical
Publication of ES2550059T3 publication Critical patent/ES2550059T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES11710383.8T 2010-03-17 2011-03-17 Método para usar una cepa de Bacillus subtilis para la profilaxis y el tratamiento de afecciones gastrointestinales Active ES2550059T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31499710P 2010-03-17 2010-03-17
US314997P 2010-03-17
PCT/US2011/028755 WO2011116155A1 (en) 2010-03-17 2011-03-17 Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Publications (1)

Publication Number Publication Date
ES2550059T3 true ES2550059T3 (es) 2015-11-04

Family

ID=44072771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11710383.8T Active ES2550059T3 (es) 2010-03-17 2011-03-17 Método para usar una cepa de Bacillus subtilis para la profilaxis y el tratamiento de afecciones gastrointestinales

Country Status (10)

Country Link
US (1) US9457054B2 (https=)
EP (1) EP2547348B1 (https=)
JP (1) JP5830084B2 (https=)
AU (1) AU2011227226B2 (https=)
DK (1) DK2547348T3 (https=)
ES (1) ES2550059T3 (https=)
MY (1) MY161197A (https=)
NZ (1) NZ603065A (https=)
PL (1) PL2547348T3 (https=)
WO (1) WO2011116155A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009293213C1 (en) * 2008-09-17 2015-04-30 Bayer Cropscience Lp Method for using a Bacillus subtilis strain to enhance animal health
EP2547348B1 (en) 2010-03-17 2015-05-20 Bayer Cropscience LP Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions
MX347345B (es) 2011-05-24 2017-04-21 Bayer Cropscience Lp Combinaciones sinergicasde fungicidas polienicos y peptidos no ribosomales y metodos de uso relacionados.
CA2865219A1 (en) * 2012-02-21 2013-08-29 Dupont Nutrition Biosciences Aps Composition
FR3007654B1 (fr) * 2013-06-27 2015-07-10 Lesaffre & Cie Composition de solute de rehydratation orale contenant des probiotiques
FR3007655B1 (fr) * 2013-06-28 2016-12-23 Lesaffre & Cie Souche bacillus subtilis pour le traitement et/ou la prevention de maladies inflammatoires chroniques
JP6440463B2 (ja) * 2013-11-15 2018-12-19 プリマハム株式会社 抗菌作用を有するバチルス・メチロトロフィカス
JP6671950B2 (ja) * 2015-12-18 2020-03-25 アサヒカルピスウェルネス株式会社 機能性胃腸症改善剤
JP7104078B2 (ja) * 2017-06-30 2022-07-20 エボニック オペレーションズ ゲーエムベーハー プロバイオティクス活性がある枯草菌株
US12194142B2 (en) 2017-09-25 2025-01-14 Deerland Enzymes, Inc. Bacillus subtilis containing composition for treatment of gastrointestinal irregularity
WO2019147799A1 (en) 2018-01-24 2019-08-01 Omnigen Research, Llc Bacillus combination for administration to animals
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
BE1027162B1 (nl) * 2019-03-29 2020-11-05 My Res Comm V Bacillus coagulans en Bacillus subtilis voor de preventie en behandeling van functionele gastro-intestinale stoornissen
US11160838B2 (en) 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions
GB201911925D0 (en) * 2019-08-20 2019-10-02 Sporegen Ltd Formulations for prevention or reduction of c. difficile infections

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62232343A (ja) 1986-04-01 1987-10-12 Kyodo Shiryo Kk 幼豚用配合飼料
JPS63209580A (ja) 1987-02-25 1988-08-31 Karupisu Shokuhin Kogyo Kk バチルス・ズブチリスc−3102
KR930001383B1 (ko) * 1990-10-31 1993-02-27 재단법인 한국화학연구소 신규의 바실러스 서브틸리스 아종 및 이로부터 생산되는 항진균 물질 krf-001 복합체의 용도
US5785990A (en) 1995-07-10 1998-07-28 Merrick's, Inc. Feed fortifier and enhancer for preruminant calves and method of using same
JP2979294B2 (ja) 1996-10-02 1999-11-15 カルピス株式会社 鳥類卵殻強度増強剤
US6103228A (en) 1997-05-09 2000-08-15 Agraquest, Inc. Compositions and methods for controlling plant pests
DK0981540T3 (da) 1997-05-09 2006-11-06 Agraquest Inc Ny Bacillus-stamme til bekæmpelse af plantesygdomme og af majsrodgnaver
US6015553A (en) 1997-08-22 2000-01-18 Agraquest, Inc. Bacillus subtilis strain for controlling insect and nematode pests
JP3260111B2 (ja) 1997-10-09 2002-02-25 伊藤忠飼料株式会社 鳥類の給餌中止時の体重減少抑制方法及び腸内有害細菌減少方法
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
JP2000166583A (ja) * 1998-10-02 2000-06-20 Shin Nihonsha:Kk 枯草菌等が産生する無機物及びその酸塩と副産物及びその誘導体
GB0124580D0 (en) 2001-10-12 2001-12-05 Univ Reading New composition
GB0130789D0 (en) 2001-12-21 2002-02-06 King S College London Application of spores
AR040927A1 (es) 2002-04-10 2005-04-27 Cooperativas Argentinas Cooper Alimento para la crianza de vacunos neonatos y procedimiento de utilizacion.
AT413191B (de) 2002-10-11 2005-12-15 Erber Ag Futtermittel- und/oder trinkwasserzusatz für nutztiere
US7247299B2 (en) * 2002-11-27 2007-07-24 Kemin Industries, Inc. Antimicrobial compounds from Bacillus subtilis for use against animal and human pathogens
EP1472933A1 (en) 2003-05-01 2004-11-03 Chr. Hansen A/S Improving health and/or nutritional status of an aquatic animal by aid of Bacillus licheniformis
US20070065540A1 (en) 2003-07-24 2007-03-22 Jones Alison M Enhanced steep-water
RU2266747C1 (ru) 2004-03-22 2005-12-27 Кубанский государственный аграрный университет Пробиотическая композиция для животных и птицы
JP2007054041A (ja) 2005-07-29 2007-03-08 Yodorinon Kenkyusho:Kk 養鶏飼料並びに卵
US20080057047A1 (en) 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
US7754469B2 (en) * 2005-11-30 2010-07-13 Agtech Products, Inc Microorganisms and methods for treating poultry
JP4968816B2 (ja) * 2006-03-08 2012-07-04 日本曹達株式会社 バチルス属細菌の芽胞形成方法
WO2007150052A1 (en) * 2006-06-23 2007-12-27 Equine Research Associates, Ltd Animal nutritional supplement and method
NZ600929A (en) * 2007-09-20 2014-02-28 Basf Se Combinations comprising a fungicidal strain and an active compound
AU2009293213C1 (en) 2008-09-17 2015-04-30 Bayer Cropscience Lp Method for using a Bacillus subtilis strain to enhance animal health
US8227235B2 (en) 2008-12-10 2012-07-24 Alpharma, Llc Compositions and methods for controlling diseases in animals
EP2547348B1 (en) 2010-03-17 2015-05-20 Bayer Cropscience LP Method for using a bacillus subtilis strain for prophylaxis and treatment of gastro-intestinal conditions

Also Published As

Publication number Publication date
US9457054B2 (en) 2016-10-04
AU2011227226B2 (en) 2017-02-16
JP2013522315A (ja) 2013-06-13
AU2011227226A1 (en) 2012-11-08
NZ603065A (en) 2014-12-24
WO2011116155A1 (en) 2011-09-22
EP2547348A1 (en) 2013-01-23
PL2547348T3 (pl) 2015-11-30
JP5830084B2 (ja) 2015-12-09
US20120328571A1 (en) 2012-12-27
DK2547348T3 (da) 2015-08-24
MY161197A (en) 2017-04-14
EP2547348B1 (en) 2015-05-20

Similar Documents

Publication Publication Date Title
ES2550059T3 (es) Método para usar una cepa de Bacillus subtilis para la profilaxis y el tratamiento de afecciones gastrointestinales
ES2561253T3 (es) Bacterias probióticas que tienen actividad antioxidante y uso de las mismas
ES2509892T3 (es) Administración de un agente para limpieza del intestino y antibiótico para el tratamiento de enfermedad intestinal
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
ECSP11010975A (es) Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales
GB2480773B (en) Compositions for the treatment of diarrhea caused by virulent E. coli infections
MX2009008577A (es) Prevencion y tratamiento contra la enfermedad asociada a arcovirus porcion sub-clinica.
AR106768A1 (es) Composiciones que comprenden cepas bacterianas
RU2008121602A (ru) Применение рв6 bacillus для профилактики или лечения желудочно- кишечных и иммунных заболеваний
WO2015047941A3 (en) Compositions and methods for treatment and prophylaxis of gastrointestinal diseases
MX2012006628A (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la piel.
CR11723A (es) Agente para tratar enfermedad
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
ES2518924T3 (es) Nuevo microorganismo y agente de control de enfermedades de las plantas usando dicho microorganismo
AR078346A1 (es) Anticuerpos humanos de alta afinidad contra el receptor activado por proteasa de tipo 2 humano
AR083395A1 (es) Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico
MX2021009398A (es) Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso.
PH12013501903A1 (en) Nutritional compositions including branched chain fatty acids for improving gut barrier function
CL2011002639A1 (es) Cepa bacteriana de mycoplasma bovis atenuada avirulenta; composicion inmunogenica que la comprende; y uso para fabricar un medicamento para infecciones producidas por m. bovis.
AR071968A1 (es) Uso de un oligosacarido en el tratamiento de la inflamacion intestinal
EP4242295A3 (en) B. amyloliquefaciens strain and therapeutic use
ECSP056189A (es) Composiciones y método para el tratamiento de infecciones en ganado vacuno y porcino
WO2008062136A3 (fr) Methode de diagnostic et de suivi d'une vaginose bacterienne par quantification moleculaire
CO6260078A2 (es) Metodo y tratamiento del trastorno por estres postraumatico mediante la administracion de un agente seleccionado entre benzodiazepina, un inhibidor (isrs) y otros
AR069943A1 (es) Metodo para reducir la circunferencia abdominal mediante la administracion de una bacteria bifidobacterium